Skip to main content
. 2021 Jun 5;21:1077. doi: 10.1186/s12889-021-11050-x

Table 1.

AIDS cases transmitted via various routes in local and immigrant populations

Variables
Groups
Heterosexual transmission Homosexual transmission Others
(N = 15,050) (N = 11,057) (N = 1201)
no. %(95%CI) no. %(95%CI) no. %(95%CI)
Sex
 Local Male 7927 52.67 (51.87–53.47) 6795 61.45 (60.54–62.36) 584 48.63 (45.76–51.49)
Female 2812 18.68 (18.06–19.32) 5 0.05 (0.01–0.11) 162 13.49 (11.61–15.56)
 Immigrant Male 2582 17.16 (16.56–17.77) 4252 38.46 (37.55–39.37) 327 27.23 (24.73–29.84)
Female 1729 11.49 (10.98–12.01) 5 0.05 (0.01–0.11) 128 10.66 (8.97–12.54)
Age groups
 Local 0–20 202 1.34 (1.16–1.54) 552 4.99 (4.59–5.41) 30 2.50 (1.69–3.55)
21–35 2643 17.56 (16.96–18.18) 3853 34.85 (33.96–35.74) 245 20.40 (18.15–22.79)
36–50 3346 22.23 (21.57–22.91) 1681 15.20 (14.54–15.89) 253 21.07 (18.79–23.48)
Over50 4548 30.22 (29.49–30.96) 714 6.46 (6.01–6.93) 218 18.15 (16.01–20.45)
 Immigrant 0–20 195 1.30 (1.12–1.49) 251 2.27 (2.00–2.57) 23 1.92 (1.22–2.86)
21–35 2190 14.55 (13.99–15.13) 2796 25.29 (24.48–26.11) 242 20.15 (17.91–22.53)
36–50 1532 10.18 (9.70–10.67) 1094 9.89 (9.34–10.47) 163 13.57 (11.68–15.64)
Over50 394 2.62 (2.37–2.89) 116 1.05 (0.87–1.26) 27 2.25 (1.49–3.25)
Marital status
 Local Unmarried 1768 11.75 (11.24–12.27) 4243 38.37 (37.47–39.29) 186 15.49 (13.49–17.66)
Married/Cohabiting 6888 45.77 (44.97–46.57) 1739 15.73 (15.05–16.42) 430 35.80 (33.09–38.59)
Divorced/Separated 1608 10.68 (10.20–11.19) 768 6.95 (6.48–7.44) 94 7.83 (6.37–9.49)
Widowed 460 3.06 (2.79–3.34) 39 0.35 (0.25–0.48) 21 1.75 (1.09–2.66)
Unknown 18 0.12 (0.07–0.19) 11 0.10 (0.05–0.18) 15 1.25 (0.70–2.05)
 Immigrant Unmarried 1152 7.65 (7.23–8.09) 2713 24.54 (23.74–25.35) 147 12.24 (10.44–14.23)
Married/Cohabiting 2390 15.88 (15.30–16.47) 987 8.93 (8.40–9.47) 236 19.65 (17.44–22.01)
Divorced/Separated 648 4.31 (3.99–4.64) 542 4.90 (4.51–5.32) 53 4.41 (3.32–5.73)
Widowed 110 0.73 (0.60–0.88) 11 0.10 (0.05–0.18) 10 0.83 (0.40–1.53)
Unknown 11 0.07 (0.04–0.13) 4 0.04 (0.01–0.09) 9 0.75 (0.34–1.42)
Clinical stage
 Local Clinical phase I 6347 42.17 (41.38–42.97) 4187 37.87 (36.96–38.78) 512 42.63 (39.81–45.48)
Clinical phase II 1964 13.05 (12.52–13.60) 1534 13.87 (13.23–14.53) 101 8.41 (6.90–10.12)
Clinical phase III 1492 9.91 (9.44–10.40) 699 6.32 (5.88–6.79) 87 7.24 (5.84–8.86)
Clinical phase IV 936 6.22 (5.84–6.62) 380 3.43 (3.10–3.79) 46 3.83 (2.82–5.08)
 Immigrant Clinical phase I 2861 19.01 (18.39–19.65) 2560 23.15 (22.37–23.95) 312 25.98 (23.52–28.56)
Clinical phase II 899 5.97 (5.60–6.36) 1185 10.72 (10.15–11.31) 94 7.83 (6.37–9.49)
Clinical phase III 352 2.34 (2.10–2.59) 345 3.12 (2.80–3.46) 35 2.91 (2.04–4.03)
Clinical phase IV 199 1.32 (1.15–1.52) 167 1.51 (1.29–1.76) 14 1.17 (0.64–1.95)